Dr. Jeyarajah meets with his patients who survived extremely challenging cancer diagnoses. From esophageal and colon, to pancreatic cancer, Dr Jeyarajah has been able to provide relief in the midst of these daunting and difficult diseases. These brave patients graciously share their stories about their treatment and path to recovery under Dr Jeyarajah and his team.
Colonel Jason Julian is back home in Texas after 26 years on active duty in the U.S. Marine Corps. A sixth-generation Texan, he always planned to return with his family after retiring from his post in Virginia. The Plano native and Marine just didn’t expect that cancer would be involved in bringing him back. Two years, two surgeries, and 12 rounds of chemotherapy later, Jason says he feels “blessed with the best outcome possible.” He’ll get no argument from his doctor, D. Rohan Jeyarajah, MD, FACS, director of gastrointestinal surgical services and head of the hepatopancreaticobiliary surgery fellowship program at Methodist Richardson Medical Center. “Jason’s story shows that for some colorectal cancer patients, there is a chance for long-term survival, potentially a cure,” Dr. Jeyarajah says.
ACS Regent Steven Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS (ED), FRCSI (Hon), Hon FRCS (Glasg), Director, Digestive Disease Center at Cleveland Clinic Florida in Weston, speaks with D. Rohan Jeyarajah, MD. Dr. Jeyrajah is chair, department of surgery, Texas Christian University and University of North Texas Health Science Center School of Medicine, Methodist Richardson Medical Center, Dallas, TX. In his conversation with Dr. Wexner he discusses how COVID-19 has affected his work in private practice, including efforts to keep his practice funded and preserve staff jobs, while also maintaining safety for urgent surgery patients during an unprecedented public health event.
Methodist Richardson Medical Center is proud to announce it is the first hospital in the country to earn The Joint Commission’s Gold Seal of Approval® for Pancreatic/Hepatic/Biliary Cancer Certification. The Gold Seal of Approval is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care. “We know we are as good or better than any place in the country with regard to outcomes for these cancers,” says Rohan Jeyarajah, MD, Director of GI Surgical Services. “This really puts Methodist Richardson on the map since we are first in the nation.”
Say Yes to Hope hosts Dr. Jeyarajah for a discussion about metastatic liver disease. He describes the perspective of a surgeon when establishing a treatment plan, as well as the challenges in the early stages of diagnosing these types of cancers. Dr. Jeyarajah also shares his insight in the importance of establishing spiritual and personal connections to patients and their families while navigating the path to recovery.
Hepatobiliary surgeon D. Rohan Jeyarajah, MD, FACS, performed the first robotic Whipple procedure in Collin County on a pancreatic cancer patient at Methodist Richardson Medical Center.
Dr. Rohan Jeyarajah discusses the Purple for Pancreas event at Methodist Dallas on WFAA. Methodist Dallas Medical Center is the first hospital in the nation awarded certification by The Joint Commission for pancreatic surgery and the first in Texas awarded certification for pancreatic cancer.